These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 34391850)

  • 1. Poly(caprolactone)-based subcutaneous implant for sustained delivery of levothyroxine.
    Stewart SA; Domínguez-Robles J; Utomo E; Picco CJ; Corduas F; Mancuso E; Amir MN; Bahar MA; Sumarheni S; Donnelly RF; Permana AD; Larrañeta E
    Int J Pharm; 2021 Sep; 607():121011. PubMed ID: 34391850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPLC method for levothyroxine quantification in long-acting drug delivery systems. Validation and evaluation of bovine serum albumin as levothyroxine stabilizer.
    Stewart SA; Waite D; Domínguez-Robles J; McAlister E; Permana AD; Donnelly RF; Larrañeta E
    J Pharm Biomed Anal; 2021 Sep; 203():114182. PubMed ID: 34089980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly(caprolactone)-Based Coatings on 3D-Printed Biodegradable Implants: A Novel Strategy to Prolong Delivery of Hydrophilic Drugs.
    Stewart SA; Domínguez-Robles J; McIlorum VJ; Gonzalez Z; Utomo E; Mancuso E; Lamprou DA; Donnelly RF; Larrañeta E
    Mol Pharm; 2020 Sep; 17(9):3487-3500. PubMed ID: 32672976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of 3D-printed subcutaneous implants using concentrated polymer/drug solutions.
    Picco CJ; Utomo E; McClean A; Domínguez-Robles J; Anjani QK; Volpe-Zanutto F; McKenna PE; Acheson JG; Malinova D; Donnelly RF; Larrañeta E
    Int J Pharm; 2023 Jan; 631():122477. PubMed ID: 36509226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) (PCL-PEG-PCL) nanoparticles for honokiol delivery in vitro.
    Gou M; Zheng L; Peng X; Men K; Zheng X; Zeng S; Guo G; Luo F; Zhao X; Chen L; Wei Y; Qian Z
    Int J Pharm; 2009 Jun; 375(1-2):170-6. PubMed ID: 19427143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute toxicity evaluation of in situ gel-forming controlled drug delivery system based on biodegradable poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) copolymer.
    Fang F; Gong CY; Dong PW; Fu SZ; Gu YC; Guo G; Zhao X; Wei YQ; Qian ZY
    Biomed Mater; 2009 Apr; 4(2):025002. PubMed ID: 19208940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly(epsilon-caprolactone)/poly(ethylene glycol)/poly(epsilon-caprolactone) nanoparticles: preparation, characterization, and application in doxorubicin delivery.
    Gou M; Zheng X; Men K; Zhang J; Zheng L; Wang X; Luo F; Zhao Y; Zhao X; Wei Y; Qian Z
    J Phys Chem B; 2009 Oct; 113(39):12928-33. PubMed ID: 19736995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3D-printed reservoir-type implants containing poly(lactic acid)/poly(caprolactone) porous membranes for sustained drug delivery.
    Korelidou A; Domínguez-Robles J; Magill ER; Eleftheriadou M; Cornelius VA; Donnelly RF; Margariti A; Larrañeta E
    Biomater Adv; 2022 Aug; 139():213024. PubMed ID: 35908473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of implant diameter, drug loading and end-capping on praziquantel release from PCL implants.
    Li C; Cheng L; Zhang Y; Guo S; Wu W
    Int J Pharm; 2010 Feb; 386(1-2):23-9. PubMed ID: 19895876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and evaluation of biodegradable films containing the potent osteogenic compound BFB0261 for localized delivery.
    Umeki N; Sato T; Harada M; Takeda J; Saito S; Iwao Y; Itai S
    Int J Pharm; 2011 Feb; 404(1-2):10-8. PubMed ID: 21047548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacometrics and delivery of novel nanoformulated PEG-b-poly(epsilon-caprolactone) micelles of rapamycin.
    Yáñez JA; Forrest ML; Ohgami Y; Kwon GS; Davies NM
    Cancer Chemother Pharmacol; 2008 Jan; 61(1):133-44. PubMed ID: 17393166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymeric matrix for drug delivery: honokiol-loaded PCL-PEG-PCL nanoparticles in PEG-PCL-PEG thermosensitive hydrogel.
    Gou M; Gong C; Zhang J; Wang X; Wang X; Gu Y; Guo G; Chen L; Luo F; Zhao X; Wei Y; Qian Z
    J Biomed Mater Res A; 2010 Apr; 93(1):219-26. PubMed ID: 19557789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo pharmacokinetics of celecoxib loaded endcapped PCLA-PEG-PCLA thermogels in rats after subcutaneous administration.
    van Midwoud PM; Sandker M; Hennink WE; de Leede LGJ; Chan A; Weinans H
    Eur J Pharm Biopharm; 2018 Oct; 131():170-177. PubMed ID: 30075312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tailored protein release from biodegradable poly(ε-caprolactone-PEG)-b-poly(ε-caprolactone) multiblock-copolymer implants.
    Stanković M; Tomar J; Hiemstra C; Steendam R; Frijlink HW; Hinrichs WL
    Eur J Pharm Biopharm; 2014 Jul; 87(2):329-37. PubMed ID: 24602675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation and Evaluation of Atorvastatin Calcium-Poly-ε-Caprolactone Nanoparticles Loaded Ocular Inserts for Sustained Release and Antiinflammatory Efficacy.
    Girgis GNS
    Curr Pharm Biotechnol; 2020; 21(15):1688-1698. PubMed ID: 32427080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute toxicity evaluation of biodegradable in situ gel-forming controlled drug delivery system based on thermosensitive PEG-PCL-PEG hydrogel.
    Gong CY; Wu QJ; Dong PW; Shi S; Fu SZ; Guo G; Hu HZ; Zhao X; Wei YQ; Qian ZY
    J Biomed Mater Res B Appl Biomater; 2009 Oct; 91(1):26-36. PubMed ID: 19365823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3D-printed implantable devices with biodegradable rate-controlling membrane for sustained delivery of hydrophobic drugs.
    Picco CJ; Domínguez-Robles J; Utomo E; Paredes AJ; Volpe-Zanutto F; Malinova D; Donnelly RF; Larrañeta E
    Drug Deliv; 2022 Dec; 29(1):1038-1048. PubMed ID: 35363100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteogenic poly(ε-caprolactone)/poloxamine homogeneous blends prepared by supercritical foaming.
    de Matos MB; Puga AM; Alvarez-Lorenzo C; Concheiro A; Braga ME; de Sousa HC
    Int J Pharm; 2015 Feb; 479(1):11-22. PubMed ID: 25541145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly(lactic acid)-poly(ethylene glycol) nanoparticles as new carriers for the delivery of plasmid DNA.
    Perez C; Sanchez A; Putnam D; Ting D; Langer R; Alonso MJ
    J Control Release; 2001 Jul; 75(1-2):211-24. PubMed ID: 11451511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amphiphilic toothbrushlike copolymers based on poly(ethylene glycol) and poly(epsilon-caprolactone) as drug carriers with enhanced properties.
    Zhang W; Li Y; Liu L; Sun Q; Shuai X; Zhu W; Chen Y
    Biomacromolecules; 2010 May; 11(5):1331-8. PubMed ID: 20405912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.